Gopala Rangan
Overview
Explore the profile of Gopala Rangan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mallawaarachchi A, McCarthy H, Forbes T, Jayasinghe K, Patel C, Alexander S, et al.
BMC Nephrol
. 2025 Feb;
26(1):51.
PMID: 39901087
Background: Genetic kidney disease (GKD) significantly affects the community and is responsible for a notable portion of adult kidney disease cases and about half of cases in paediatric patients. It...
2.
Rangan G, Allman-Farinelli M, Boudville N, Fernando M, Haloob I, Harris D, et al.
Clin Kidney J
. 2024 Aug;
17(7):sfae159.
PMID: 39165901
Background: The aim of this study was to determine the long-term effect of increasing water intake in patients with autosomal dominant polycystic kidney disease (ADPKD) on longitudinal changes in health-related...
3.
Jayasinghe K, Biros E, Harris T, Wood A, OShea R, Hill L, et al.
Kidney Int Rep
. 2024 Aug;
9(8):2372-2385.
PMID: 39156154
Introduction: Diagnostic genomic sequencing is the emerging standard of care in nephrology. There is a growing need to scale up the implementation of genomic diagnostics nationally to improve patient outcomes....
4.
Bettler T, Vucak-Dzumhur M, Rangan G, Elder G
Perit Dial Int
. 2024 Jun;
:8968608241256846.
PMID: 38860361
A man with hyperparathyroidism secondary to kidney failure on peritoneal dialysis underwent a parathyroidectomy with half-gland reimplantation complicated by severe hungry bone syndrome resulting in severe hypocalcaemia, hypotension and QT...
5.
Mallett A, Perrone R, Rangan G, Hawley C, El-Damanawi R, Hiemstra T, et al.
Kidney Int Rep
. 2021 Apr;
6(4):1032-1040.
PMID: 33912753
Introduction: In pivotal trials of patients with autosomal dominant polycystic kidney disease at risk of rapid progression, tolvaptan slowed estimated glomerular filtration rate (eGFR) decline in early-to-moderate (TEMPO 3:4 [NCT00428948])...
6.
Mallawaarachchi A, Lundie B, Hort Y, Schonrock N, Senum S, Gayevskiy V, et al.
Eur J Hum Genet
. 2021 Jan;
29(5):760-770.
PMID: 33437033
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is common, with a prevalence of 1/1000 and predominantly caused by disease-causing variants in PKD1 or PKD2. Clinical diagnosis is usually by age-dependent imaging...
7.
Cho Y, Tong A, Craig J, Mustafa R, Chapman A, Perrone R, et al.
Am J Kidney Dis
. 2020 Aug;
77(2):255-263.
PMID: 32771648
The omission of outcomes that are of relevance to patients, clinicians, and regulators across trials in autosomal dominant polycystic kidney disease (ADPKD) limits shared decision making. The Standardized Outcomes in...
8.
Cho Y, Rangan G, Logeman C, Ryu H, Sautenet B, Perrone R, et al.
Am J Kidney Dis
. 2020 May;
76(3):361-373.
PMID: 32359822
Rationale & Objective: Outcomes reported in trials involving patients with autosomal dominant polycystic kidney disease (ADPKD) are heterogeneous and rarely include patient-reported outcomes. We aimed to identify critically important consensus-based...
9.
Sautenet B, Cho Y, Gutman T, Rangan G, Ong A, Chapman A, et al.
Am J Kidney Dis
. 2020 Mar;
76(2):213-223.
PMID: 32171640
Rationale & Objective: Trials in autosomal dominant polycystic kidney disease (ADPKD) have increased, but their impact on decision making has been limited. Because heterogeneity in reported outcomes may be responsible,...
10.
Cho Y, Sautenet B, Gutman T, Rangan G, Craig J, Ong A, et al.
Nephrology (Carlton)
. 2019 Jan;
24(12):1214-1224.
PMID: 30663163
Aim: Patients with autosomal dominant polycystic kidney disease (ADPKD) are at increased risk of premature mortality, morbidities and complications, which severely impair quality of life. However, patient-centered outcomes are not...